Generic-drug makers’ complaints over brand-name access prompt investigations

Generic-drug makers’ complaints over brand-name access prompt investigations:
Some drugmakers assert they are unable to create cheaper generic versions of drugs because their rivals are exploiting a legal loophole.
It all comes down to process: To get a generic drug approved for sale, a company has to test a sample of the brand-name version and show regulators that the generic version is essentially identical and as effective.
Read full article >>